AGA expert review (not systematic, no evidence grading) on adult C difficile infection: fidaxomicin favoured first line for nonfulminant disease, vancomycin acceptable, metronidazole only in fulminant disease; faecal microbiota therapies after a second recurrence.
Guideline
Fischer et al. AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Adults: Expert Review